Literature DB >> 7705884

Interleukin-1 beta-induced neutrophil recruitment and acute lung injury in hamsters.

L M Patton1, B S Saggart, N K Ahmed, J A Leff, J E Repine.   

Abstract

Administering recombinant interleukin-1 beta (IL-1 beta) intratracheally caused lung neutrophil accumulation and lung injury in hamsters. The percentage of leukocytes that were neutrophils increased progressively in lavages from lungs of hamsters given 25, 50, or 100 ng IL-1 beta intratracheally 2 h before. Lung injury, reflected by increased lung lavage protein concentrations and lung lavage hemoglobin concentrations, increased 2 h after administering 100 ng IL-1 beta. Lung injury, reflected by lung wet weight/body weight ratios, followed similar patterns, with significant increases occurring 2 h after insufflating 50 or 100 ng IL-1. Our results indicate that increased concentrations of IL-1 beta in lung airways can cause neutrophil recruitment and lung injury in hamsters. This mechanism may contribute to the development of lung neutrophil accumulation and lung injury that characterizes ARDS patients who have increased airway levels of IL-1 beta.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705884     DOI: 10.1007/bf01534377

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  20 in total

Review 1.  Scientific perspectives on adult respiratory distress syndrome.

Authors:  J E Repine
Journal:  Lancet       Date:  1992-02-22       Impact factor: 79.321

2.  Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-alpha.

Authors:  M B Furie; D D McHugh
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

3.  High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis.

Authors:  P M Suter; S Suter; E Girardin; P Roux-Lombard; G E Grau; J M Dayer
Journal:  Am Rev Respir Dis       Date:  1992-05

4.  Intratracheal but not intravascular interleukin-1 causes acute edematous injury in isolated neutrophil-perfused rat lungs through an oxygen radical-mediated mechanism.

Authors:  D M Guidot; E E Stevens; M J Repine; A E Lucca-Broco; J E Repine
Journal:  J Lab Clin Med       Date:  1994-04

5.  Increased superoxide anion release from human endothelial cells in response to cytokines.

Authors:  T Matsubara; M Ziff
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

6.  Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome.

Authors:  T M Siler; J E Swierkosz; T M Hyers; A A Fowler; R O Webster
Journal:  Exp Lung Res       Date:  1989-12       Impact factor: 2.459

7.  Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms.

Authors:  L H Faccioli; G E Souza; F Q Cunha; S Poole; S H Ferreira
Journal:  Agents Actions       Date:  1990-06

8.  The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation.

Authors:  T R Ulich; S M Yin; K Z Guo; J del Castillo; S P Eisenberg; R C Thompson
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

9.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

Authors:  S Okusawa; J A Gelfand; T Ikejima; R J Connolly; C A Dinarello
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

10.  Recombinant interleukin 1 alpha and beta prime human monocyte superoxide production but have no effect on chemotaxis and oxidative burst response of neutrophils.

Authors:  A Kharazmi; H Nielsen; K Bendtzen
Journal:  Immunobiology       Date:  1988-04       Impact factor: 3.144

View more
  9 in total

1.  Effects of age on the synergistic interactions between lipopolysaccharide and mechanical ventilation in mice.

Authors:  Lincoln S Smith; Sina A Gharib; Charles W Frevert; Thomas R Martin
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-09       Impact factor: 6.914

Review 2.  Animal models of enteroaggregative Escherichia coli infection.

Authors:  Casandra W Philipson; Josep Bassaganya-Riera; Raquel Hontecillas
Journal:  Gut Microbes       Date:  2013-05-02

3.  The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury.

Authors:  Heather D Jones; Timothy R Crother; Romer A Gonzalez-Villalobos; Madhulika Jupelli; Shuang Chen; Jargalsaikhan Dagvadorj; Moshe Arditi; Kenichi Shimada
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

4.  Sex-specific differences in hyperoxic lung injury in mice: implications for acute and chronic lung disease in humans.

Authors:  Krithika Lingappan; Weiwu Jiang; Lihua Wang; Xanthi I Couroucli; Roberto Barrios; Bhagavatula Moorthy
Journal:  Toxicol Appl Pharmacol       Date:  2013-06-21       Impact factor: 4.219

5.  Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice.

Authors:  Richard A Johnston; Joseph P Mizgerd; Lesley Flynt; Lee J Quinton; Erin S Williams; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

6.  Alpha-4/beta-1 and alpha-L/beta-2 integrins mediate cytokine induced lung leukocyte-epithelial adhesion and injury.

Authors:  L A Parmley; N D Elkins; M A Fini; Y-E Liu; J E Repine; R M Wright
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

7.  Effects of elevated CO2 levels on lung immune response to organic dust and lipopolysaccharide.

Authors:  David Schneberger; Upkardeep Pandher; Brooke Thompson; Shelley Kirychuk
Journal:  Respir Res       Date:  2021-04-09

Review 8.  Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection.

Authors:  Mohammad Islamuddin; Salman Ahmad Mustfa; Shehla Nasar Mir Najib Ullah; Usmaan Omer; Kentaro Kato; Shama Parveen
Journal:  Inflammation       Date:  2022-08-11       Impact factor: 4.657

Review 9.  Targeting the NLRP3 Inflammasome in Severe COVID-19.

Authors:  Tracey L Freeman; Talia H Swartz
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.